Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Drugs Made In America Acquisition (DMAA) Equity Ratio (2024 - 2025)

Drugs Made In America Acquisition filings provide 2 years of Equity Ratio readings, the most recent being 0.03 for Q4 2025.

  • Quarterly Equity Ratio rose 93.19% to 0.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03 through Dec 2025, up 93.19% year-over-year, with the annual reading at 0.03 for FY2025, 93.19% up from the prior year.
  • Equity Ratio hit 0.03 in Q4 2025 for Drugs Made In America Acquisition, up from 0.03 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.03 in Q4 2025 and bottomed at 0.44 in Q4 2024.